Liquid Biopsy refers to the collection and analysis of body fluids such as blood, urine, cerebrospinal fluid and pleural or peritoneal effusions for the purpose of diagnosing or monitoring diseases. This method is gaining increasing importance, particularly in oncology, as malignant tumors release whole cells, cell-free tumor DNA, exosomes and other...

At this year’s annual meeting of the American Association for Cancer Research (AACR), held from April 25th to 30th, 2025, in Chigaco, USA, Pachmann GmbH & Co. KG, Simfo GmbH presented current research findings in three poster presentations on circulating tumor cells and cancer stem cells. Professor Dr. Pachmann and PD...

Circulating cancer stem cells (cCSCs) play a crucial role in the development of metastasis and cancer progression. Since their first scientific description in the early 2000s, they have become an increasing focus of cancer research. ...

Bayreuth, February 25th, 2025 A recent study conducted by the laboratory Pachmann in Bayreuth, Germany, and the Department of Radiation Oncology at the University Hospital of Jena, Germany, has shown that circulating epithelial tumor cells (CETC/CTC) can be used as a biomarker to assess the risk of recurrence in prostate cancer...

Member of the German Bundestag (National parliament of the Federal Republic of Germany) Johannes Wagner visited the internationally active laboratory Pachmann in Bayreuth to gain an insight into the challenges facing small and medium-sized enterprises (SMEs) in the medical sector. The visit focused on the urgent need for government support in...

Liquid Biopsy offers new perspectives in cancer treatment. With blood tests, cancer can be monitored, therapies can be checked for their effectiveness and changes in tumor behavior can be detected at an early stage. This allows the therapy to be individually adapted to ensure the most effective treatment possible - an...

The laboratory Dr. Pachmann in Bayreuth, in collaboration with the University and University Hospital of Regensburg, played a key role in conducting the study “Patientderived xenografts from circulating cancer stem cells as a preclinical model for personalized pancreatic cancer research” [Wagner et al., 2025], which was published in the journal Scientific...